Ana C. Garrido-Castro, MD, on Managing Metastatic Breast Cancer in 2024 ascopost.com/videos/2024-as… #bcsm #breastcancer #oncology #ASCO24 #DanaFarber #DanaFarber News

ASCO Highlights: SACI-IO presented by Dr. Ana Garrido-Castro from Dana-Farber generated significant discussion from the KOL Community. View their discussion of the data and also other slides and video media about this important study. #ASCO24
#BCSM
beta.kolpulse.com/public/1409290…

🇵🇹 🇧🇷 Novas possibilidades de uso de anticorpos conjugados contra o câncer. Obrigado Roberto Pestana, MD por me convidar para esta entrevista no #ASCO24 ! youtu.be/qZsJ5Tlv1vY?si…

Please consider attending the School of Breast Oncology Nov 7-9th in Atlanta led by Joyce O'Shaughnessy; it is really a fabulous and comprehensive program that teaches every aspect of breast cancer care.

Use my last name (TOLANEY) for free registration.

gotoper.com/courses/school…

Dear Colleagues,
Our Friends/Collaborators at VJ Oncology would like to invite you to attend their POST #ASCO24 🇺🇸 Highlights

June 19 #LungCancer with Sanjay Popat 🇬🇧
June 20 GU #Cancer with Tom Powles 🇬🇧
June 21 #BreastCancer with Sara Tolaney 🇺🇸
June 24 GI Cancer with

Join us for our Post-ASCO 2024 #BreastCancer Highlights 📣

🗓️ 21 June 2024
📍Webinar 💻

🌟 Chaired by Dr Sara Tolaney
💬 Moderators: Giuseppe Curigliano & Erika Hamilton, MD

Featuring presentations & panel discussions on selected abstracts by leading #Oncology experts from #ASCO

Tune in NOW for Breast Cancer Breakthroughs! Find out why people with early-stage ER+ #breastcancer need more options despite having a good prognosis from Sara Tolaney & Aditya Bardia, MD. Click here to watch: bit.ly/3X1yPW0

Inviting you to register to this Virtual webinar hosted by our collaborators at VJ Oncology on selected abstracts in #BreastCancer from #ASCO24

Link to Register: us06web.zoom.us/webinar/regist…

Date: June 21, 2024 (5pm CEST) Chaired by
Sara Tolaney 🇺🇸

After breast cancer treatment, Sandra Noack seized an opportunity to improve her health at a time when her family needed her but she wasn’t feeling her strongest. A clinical trial helped her improve her strength, mobility, and more.

ms.spr.ly/6011YUz7R

PI3K/Akt-targeted agents entered clinical practice & may soon bring precision oncology to 1st line of Tx for ER+ breast cancer
 
Out in Critical Reviews in Oncology Hematology (CROH) our review on the activity, biomarkers & toxicities w/ these agents & next steps in the field

tinyurl.com/PI3KAkt

OncoAlert

Register today for the Society for Immunotherapy of Cancer Summit on Immunomodulation of #AntibodyDrugConjugates
🗓️Wed, June 26
⏰ 11am–3:30pm EDT
The virtual summit is a free, public event featuring speakers, expert panel discussions & Q&A periods.
#SITCresearchsolutions #ADCs
👉sitcancer.org/education/webi…

Physician-level variation in axillary surgery in older adults with T1N0 hormone receptor-positive #breastcancer - retrospective population-based cohort study now available to all in Journal of Geriatric Oncology.
christinaminami Rachel Freedman, MD, MPH Tari King MD Dr. E Mittendorf
👉pubmed.ncbi.nlm.nih.gov/38759256/

Results from the Phase III TROPiCS-02 trial on health-related quality of life with sacituzumab govitecan in HR+/HER2- #MetastaticBreastCancer are now available in the The Oncologist.
Read it here👇
pubmed.ncbi.nlm.nih.gov/38748596/
Hope Rugo Sara Tolaney Javier Cortes MD PhD Aditya Bardia, MD

ADCs have shortened distances between scientists globally, with the partnership between West & East leading to major advancements in oncology.

Glad to push this collaboration forward through the monthly 🌎Global Young JC- today, with great Trop2 lectures by Drs Punie, Fan & Shi!

Join us on June 20 at 1 PM CT for our virtual MBC Impact Series webinar featuring Dr. Heather Parsons of Dana-Farber. Dr. Parsons will dive deep into her incredible work on advancing treatments and clinical trials for HER2+ patients: bit.ly/3yY5vJJ

Our X Spaces is live! Join Neil Iyengar and Paolo Tarantino for a lively discussion on #bcsm updates from #ASCO24 !

On June 25, Ann Partridge MD, MPH, Director of the Adult Survivorship Program Dana-Farber, will join The Atlantic's People v. Cancer to discuss how we can set cancer survivors up for success.

Register to attend the free event in NYC or virtually: ms.spr.ly/6016YtFPK #PeopleVCancer

Register for the #HarvardBreastCourse !
The 2-day course will cover mechanisms of disease, improvements in diagnostic methods, treatment innovations, management of #BreastCancer survivors, and will feature a patient advocate panel!
Full Agenda Details👇
cmecatalog.hms.harvard.edu/breast-cancer-…

We congratulate Nolan Priedigkeit, MD, PhD, the 2024 AACR-Conquer Cancer®, the ASCO Foundation Young Investigator Award for Translational Cancer Research recipient. He will explore the use of fusion RNAs for treatment delivery in metastatic breast cancer.
Conquer Cancer, the ASCO Foundation

The most highly awaited day of the year at Dana-Farber’s Breast Oncology Center: Hal Burstein’s (@DrHBurstein) post-ASCO lecture!

Known to master the art of finding patterns in the data, he noticed a statistically significant trend among 🇮🇹 fellows presenting posters at #ASCO24 🤌